Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 81.61M | 83.07M | 106.04M | 104.51M | 60.40M | 45.16M |
Gross Profit | 11.87M | 14.40M | 18.73M | 21.09M | 12.24M | 7.33M |
EBITDA | 586.56K | -323.37K | 6.58M | 8.27M | 3.93M | -1.89M |
Net Income | -2.76M | -3.85M | 909.41K | 8.64M | 1.32M | -5.15M |
Balance Sheet | ||||||
Total Assets | 54.25M | 58.17M | 68.37M | 78.50M | 43.80M | 26.29M |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 0.00 | -1.94M | -7.48M | -1.78M |
Total Debt | 21.57M | 17.70M | 31.00M | 39.59M | 23.89M | 12.63M |
Total Liabilities | 35.21M | 38.56M | 45.83M | 56.09M | 32.08M | 15.73M |
Stockholders Equity | 19.04M | 19.61M | 22.54M | 22.41M | 11.72M | 10.56M |
Cash Flow | ||||||
Free Cash Flow | 10.82M | 9.97M | 12.00M | -10.67M | -9.26M | 10.22M |
Operating Cash Flow | 11.17M | 10.39M | 12.69M | -8.57M | -9.22M | 10.22M |
Investing Cash Flow | -349.99K | -414.09K | -676.64K | -2.10M | 40.11K | 1.43K |
Financing Cash Flow | -10.82M | -9.97M | -12.01M | 10.67M | 9.18M | -10.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | C$395.38M | 6.37 | 11.38% | 3.74% | 11.02% | 102.23% | |
74 Outperform | C$191.39M | 6.10 | 16.11% | ― | 18.29% | -94.32% | |
66 Neutral | C$342.08M | 151.92 | -3.90% | ― | -5.98% | -121.37% | |
65 Neutral | C$294.60M | 16.20 | 3.00% | ― | -5.50% | -88.55% | |
61 Neutral | $10.92M | 0.43 | -3.83% | 423.53% | -86.21% | ― | |
52 Neutral | C$2.91B | -1.05 | -3.46% | 5.87% | 3.01% | -47.13% | |
46 Neutral | C$7.14M | ― | -13.50% | ― | -21.66% | -523.55% |
Bri-Chem Corp. reported a significant decline in its financial performance for the fourth quarter of 2024, with consolidated sales dropping by 23% to $20.6 million due to decreased U.S. drilling activity. The company’s adjusted EBITDA and operating earnings also saw substantial decreases, alongside a notable reduction in working capital, which was impacted by a loan classification change. Despite these challenges, Bri-Chem received a waiver for a covenant breach from its lender, indicating ongoing financial adjustments and potential future stability.